Vancouver
Albayrak A, Albayrak M, Arıkök AT, Ünal TDK, Yılmazer D. An exceedingly rare entity: Mixed cellular type primary Hodgkin. J Clin Exp Invest. 2012;3(4):533-5. https://doi.org/10.5799/ahinjs.01.2012.04.0216
APA
Albayrak, A., Albayrak, M., Arıkök, A. T., Ünal, T. D. K., & Yılmazer, D. (2012). An exceedingly rare entity: Mixed cellular type primary Hodgkin. Journal of Clinical and Experimental Investigations, 3(4), 533-535. https://doi.org/10.5799/ahinjs.01.2012.04.0216
AMA
Albayrak A, Albayrak M, Arıkök AT, Ünal TDK, Yılmazer D. An exceedingly rare entity: Mixed cellular type primary Hodgkin. J Clin Exp Invest. 2012;3(4), 533-535. https://doi.org/10.5799/ahinjs.01.2012.04.0216
Chicago
Albayrak, Aynur, Murat Albayrak, Ata Türker Arıkök, Tuba Dilay Kökenek Ünal, and Demet Yılmazer. "An exceedingly rare entity: Mixed cellular type primary Hodgkin". Journal of Clinical and Experimental Investigations 2012 3 no. 4 (2012): 533-535. https://doi.org/10.5799/ahinjs.01.2012.04.0216
Harvard
Albayrak, A., Albayrak, M., Arıkök, A. T., Ünal, T. D. K., and Yılmazer, D. (2012). An exceedingly rare entity: Mixed cellular type primary Hodgkin. Journal of Clinical and Experimental Investigations, 3(4), pp. 533-535. https://doi.org/10.5799/ahinjs.01.2012.04.0216
MLA
Albayrak, Aynur et al. "An exceedingly rare entity: Mixed cellular type primary Hodgkin". Journal of Clinical and Experimental Investigations, vol. 3, no. 4, 2012, pp. 533-535. https://doi.org/10.5799/ahinjs.01.2012.04.0216